Prevention of Spinal Induced Shivering During CS

• Status: Completed
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study compares the efficacy of two different doses of intravenous (IV) granisetron on the prevention of postspinal shivering during cesarean section, in comparison with placebo.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Granisetron; Meperidine

Criteria

Inclusion Criteria:

• pregnant women at term,

• ASA status I or II (American Society of Anesthesiologists) physical status class I-II,

• low-risk cesarean section,

• Scheduled for the spinal anesthesia

Exclusion Criteria:

• Pregnant women in labor

• Patients who have the body temperature over 37.3 or less than 37 celsius degree

• Known allergies to the study drugs

• Contraindication to spinal anesthesia